Please assess the completion status of the following clinical trial:

Trial Title: Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged 1 month- 12 years, who are intubated and mechanically ventilated with the following criteria of Acute Respiratory Distress Syndrome:~  1. Acute presentation within 1 week of a known clinical insult or new/ worsening respiratory symptoms~ 2. Bilateral opacities on chest imaging - not fully explained by effusions, lobar/lung collapse, or nodules~ 3. Respiratory failure is not fully explained by cardiac failure or fluid overload (Echocardiographic assessment to exclude hydrostatic edema)~ 4. Impaired oxygenation with PaO2/ FiO2 ratio less than 300 or Oxygenation Index greater than 5.3~Exclusion Criteria:~* Greater than 24 hours since diagnosis of ARDS~* Co-existing raised intra-cranial pressure/ any other condition necessitating use of high dose of sedation (likely to suppress spontaneous breathing)~* Radiologically confirmed air leak prior to randomization - Pneumothorax/ Pulmonary interstitial Emphysema~* Clinical evidence of significant airway obstruction/ severe bronchospasm / reactive airway disease~* Have received mechanical ventilation for more than 72 hours (before meeting inclusion criteria)~* Symptomatic or uncorrected congenital heart disease or a right to left intra-cardiac shunt~* Any underlying condition that is likely to impair spontaneous respiratory drive/ efforts (Eg: Brainstem dysfunction, neuromuscular paralysis)~* Underlying chronic diseases (Eg: Cystic fibrosis, Chronic lung disease, etc)

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Airway pressure release ventilation arm (Type: EXPERIMENTAL): This group of children would be ventilated using the Airway pressure release ventilation (APRV) mode.~Restrictive fluid therapy, protocolized sedo-analgesia titration, steroid therapy, protocolized supportive care, protocolized early enteral nutrition would be provided to both the groups. Biomarkers would be measured in both groups.
- Low-tidal volume ventilation arm (Type: ACTIVE_COMPARATOR): Low-tidal volume ventilation using pressure-regulated volume control mode with target tidal volume of 6 ml/kg or less and other lung-protective strategies. Restrictive fluid therapy, protocolized sedo-analgesia titration, steroid therapy, protocolized supportive care, protocolized early enteral nutrition would be provided to both the groups. Biomarkers would be measured in both groups

Based on this trial design, predict the completion outcome and termination type (if applicable).